IPCI
Intellipharmaceuticals International Inc.
IPCI
IPCI
Delisted
IPCI was delisted on the 20th of March, 2019.
24 hedge funds and large institutions have $6.31M invested in Intellipharmaceuticals International Inc. in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
65% less call options, than puts
Call options by funds: $6K | Put options by funds: $17K
Holders
24
Holding in Top 10
–
Calls
$6K
Puts
$17K
Top Buyers
| 1 | +$3.79M | |
| 2 | +$1.21M | |
| 3 | +$19.3K | |
| 4 |
Barclays
London,
United Kingdom
|
+$7K |
| 5 |
FMA
FNY Managed Accounts
New York
|
+$1K |
Top Sellers
| 1 | -$867K | |
| 2 | -$288K | |
| 3 | -$37K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7K |